Home › Linfoma non Hodgkin › Ohio › Cleveland
Studi clinici su Linfoma non Hodgkin a Cleveland, OH
13 studi su Linfoma non Hodgkin cercano partecipanti presso sedi a Cleveland e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
In reclutamentoFase 1/2
- University Hospitals Seidman Cancer Center, Cleveland
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
In reclutamentoFase 1
- Cleveland Clinic, Cleveland
Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
In reclutamentoFase 1
- Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center, Cleveland
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
In reclutamentoFase 1
- Clinical Trial Site, Cleveland
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
In reclutamentoFase 1/2
- Cleveland Clinic, Cleveland
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
In reclutamentoFase 3
- Cleveland Clinical Taussig Cancer Center, Cleveland
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
In reclutamentoStudio osservazionale
- University Hospitals Case Medical Center, Cleveland
- Cleveland Clinic, Cleveland
Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab
In reclutamentoFase 1
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
In reclutamentoFase 1/2
- Cleveland Clinic, Cleveland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Mayfield Heights · a 12 mi di distanza
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
In reclutamentoFase 1
- University Hospitals Cleveland Medical Center, Cleveland
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
In reclutamentoFase 1/2
- University Hospitals Cleveland, Cleveland
Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Non-Hodgkin Lymphoma
In reclutamentoFase 1
- University Hospitals Seidman Cancer Center, Cleveland
- Taussig Cancer Institute | Cleveland Clinic, Cleveland
Studi su Linfoma non Hodgkin in altre città
- New York City, NY31 studi
- Houston, TX31 studi
- Boston, MA26 studi
- Nashville, TN21 studi
- Philadelphia, PA20 studi
- Baldwin Park, CA19 studi
- Washington, DC18 studi
- Chicago, IL18 studi
- Atlanta, GA18 studi
- Milwaukee, WI18 studi
- Columbus, OH18 studi
- Dallas, TX17 studi
Altri studi a Cleveland
- Cancro del polmone non a piccole cellule43 studi
- Cancro (tutti i tipi)36 studi
- Cancro al seno35 studi
- Cancro alla prostata34 studi
- Insufficienza cardiaca33 studi
- Cancro ovarico30 studi
- Cancro metastatico30 studi
- Cancro ai polmoni26 studi
- Cancro colorettale24 studi
- Malattie cardiovascolari22 studi
- Cancro dell'endometrio20 studi
- Leucemia mieloide acuta20 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.